ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.